Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.
Email could not be subscribed.
Thank you for signing up!
presented by Suzänne Taylor PhD, MBA, OTR/L
Financial: Suzanne Taylor receives compensation from MedBridge for this course. There is no financial interest beyond the production of this course.
Non-Financial: Suzanne Taylor has no competing non-financial interests or relationships with regard to the content presented in this course.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.
Often described as having difficulty with paying attention or concentration, difficulty with short-term memory, and feeling forgetful, cancer-related cognitive dysfunction (CRCD) affects up to 75% of cancer survivors. Up to 35% of these individuals may experience persistent cognitive impairment for months or years following treatment. In this course Dr. Suzanne Taylor details how CRCD impacts activity performance, emotional well-being, and interpersonal relationships. She then explains how therapists are best able to screen, assess the impact, evaluate, and treat those with CRCD based upon our current understanding of CRCD, current guidelines, and suspected contributing factors.
Suzänne Taylor PhD, MBA, OTR/L
Suzanne Taylor, PhD, MBA, OTR/L, has extensive experience in oncology rehabilitation including providing direct therapy interventions and presenting on state, regional, and national levels. Dr. Taylor has dedicated her career to furthering oncology rehabilitation education, research, and program development. Her clinical practice included working in areas of surgical oncology, otolaryngology, hematology and medical oncology, bone…
Read full bioEmail could not be subscribed.
Thank you for signing up!
Thank you!
1. What is Cancer-Related Cognitive Dysfunction?
In previous years, the cognitive dysfunction experienced by many cancer survivors was often dismissed as either related to the stress of cancer, or perhaps present before any oncology treatments. Previously referred to as chemo-brain, a growing body of research supports the long suspected concept that cognition may be impaired due to the cancer itself and /or cancer treatments. In this chapter Dr. Taylor explains our understanding of suspected physiological changes, premorbid conditions, and contributing factors to CRCD.
2. The Impact of Cancer-Related Cognitive Dysfunction
This chapter focuses on how CRCD impacts the cancer survivor's life on multiple levels from their sense of self and relationships through performance of everyday activities. Join Dr. Taylor as she highlights how the compounding effects of CRCD become significantly disruptive in both the cancer survivor's and their loved ones' lives.
3. Screening, Assessing, and Evaluating Cancer-Related Cognitive Dysfunction
Considering that upwards of 75% of cancer survivors experience changes in their cognitive functioning at some point between pre-diagnosis and through advanced disease, therapists should screen every client that has, or has had, cancer. At present there are no widely accepted measures to screen, assess, and evaluate CRCD, yet there are a multitude of options. Join Dr. Taylor as explains the current guidelines related to the identification and evaluation of CRCD.
4. Treating Cancer-Related Cognitive Dysfunction
Steady progress over the past decades has improved our understanding of cognitive impairments associated with cancer and cancer treatments. However, at present there are no clear guidelines for the management of CRCD. In this chapter Dr. Taylor emphasizes the need for therapists to utilize their clinical skills and knowledge to treat CRCD and improve functional abilities and quality of life for their clients. She explains how therapists can utilize a three-pronged approach of compensation, rehabilitation, and mitigation to best optimize cognitive performance.
More Courses in this Series
Email could not be subscribed.
Thank you for signing up!
For larger groups (25+ seats), request a demo to learn more about solution options and pricing for your organization. For detailed pricing and self-service check-out, visit Plans & Pricing.
Fill out the form below to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.
Fill out the form below to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.
Now Available: Epic MyChart Integration!
Optimize the patient experience by enabling access to MedBridge HEP directly from within MyChart.
Learn More
The Future of Digital MSK Care is Here
MedBridge Pathways, our new digital care platform, is purpose built to bring provider-first, therapy-driven MSK care to patients across the care continuum.
Learn More